FGF23 and stage 5 chronic kidney disease: We therefore conducted a longitudinal study to test the hypothesis that high plasma FGF-23 concentrations are associated with LV dysfunction independent of other factors that might influence systolic function in chronic dialysis patients utilizing the Homocysteine in Kidney and End Stage Renal Disease (HOST) Study [15] infrastructure.